Institutional investors purchased a net $4.8 million shares of TGTX during the quarter ended June 2019, and now own 61.11% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.3 Million shares of TG Therapeutics Inc
RA CAPITAL MANAGEMENT LLC Bought 2.4 Million shares of TG Therapeutics Inc
KLP KAPITALFORVALTNING AS Sold 1.5 Thousand shares of TG Therapeutics Inc